NASDAQ
Acumen Pharmaceuticals, Inc. (ABOS) has a free cash flow growth of -26.35% as of Friday, May 29, 2026. This represents a 561.38% decrease compared to its 12-month average of 5.71%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.